HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective protection of the gastrointestinal tract against methotrexate in the treatment of patients with trophoblastic tumors.

AuthorsA I Pavlotsky, L A Novikova, G J Svet-Moldavsky, B O Toloknov, V M Buchman, R M Radzikhovskaya
JournalCancer treatment reports (Cancer Treat Rep) Vol. 61 Issue 5 Pg. 895-7 (Aug 1977) ISSN: 0361-5960 [Print] United States
PMID196754 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Pharmaceutical Vehicles
  • Suspensions
  • Carbon
  • Folic Acid
  • Methotrexate
Topics
  • Carbon (therapeutic use)
  • Clinical Trials as Topic
  • Female
  • Folic Acid (administration & dosage, therapeutic use)
  • Gastrointestinal Diseases (chemically induced, prevention & control)
  • Humans
  • Methotrexate (adverse effects, therapeutic use)
  • Pharmaceutical Vehicles
  • Pregnancy
  • Suspensions
  • Trophoblastic Neoplasms (drug therapy)
  • Uterine Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: